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Objective: For real-time markerless tumour tracking in stereotactic lung radiotherapy, we propose a different
approach which uses patient-specific deep learning (DL) using a personalized data generation strategy, avoiding
the need for collection of a large patient data set. We validated our strategy with digital phantom simulation and
epoxy phantom studies.
Methods: We developed lung tumour tracking for radiotherapy using a convolutional neural network trained
for each phantom’s lesion by using multiple digitally reconstructed radiographs (DRRs) generated from each
phantom’s treatment planning 4D-CT. We trained tumour-bone differentiation using large numbers of training
DRRs generated with various projection geometries to simulate tumour motion. We solved the problem of using
DRRs for training and X-ray images for tracking by using the training DRRs with random contrast transformation
and random noise addition.
Results: We defined adequate tracking accuracy as the % frames satisfying <1 mm tracking error of the isocentre.
In the simulation study, we achieved 100% tracking accuracy in 3-cm spherical and 1.5×2.25×3-cm ovoid masses.
In the phantom study, we achieved 100% and 94.7% tracking accuracy in 3- and 2-cm spherical masses, respectively.
This required 32.5 ms/frame (30.8 fps) real-time processing.
Conclusions: We proved the potential feasibility of a real-time markerless tumour tracking framework for stereo-
tactic lung radiotherapy based on patient-specific DL with personalized data generation with digital phantom and
epoxy phantom studies.
Advances in Knowledge: Using DL with personalized data generation is an efficient strategy for real-time lung
tumour tracking.
I. INTRODUCTION
Image-guided radiotherapy (IGRT) is commonly used
in commercial stereotactic radiotherapy systems for fo-
cusing irradiation on a tumour subject to motion. The
technology to locate lung tumour position in real time
during irradiation is important because of the trend
towards real-time adaptive treatment. Some commer-
cial stereotactic radiotherapy systems support real-time
tracking of gold fiducial markers[1][2][3]. However,
marker implantation is invasive and carries the risks
of pneumothorax and marker migration[4]. Markerless
tracking is being investigated for the next generation of
IGRT[5][6][7]. In most cases, template matching[8][9][10]
or a correlation model[11] with X-ray images as a train-
ing data set are used. Other cases use a correla-
tion model[12] with digitally reconstructed radiographs
(DRRs) as training data sets. These methodologies in-
volve the generation of a small personalized training data
set for each patient. However, conventional template
matching and correlation models often cause robustness
problems due to inter- and intra-fractional change or in-
duced artefacts in computed tomography.
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Image recognition by machine learning, ng trackespe-
cially deep learning (DL), is another strategy to im-
prove the robustness of markerless tracking[13]. DL is
a de facto standard for robust image recognition meth-
ods. However, DL for medical imaging usually requires
multiple-subject data sets for training. Further, data col-
lection is challenging and does not always work well due
to the heterogeneity of patient data.
Here, we propose a different strategy using patient-
specific DL with large personalized training data sets
generated from individual patients for real-time mark-
erless lung tumour tracking, avoiding the need for col-
lection of a large patient data set. Our strategy uses a
personalized training data set generated from each pa-
tient’s 4-dimensional treatment planning computed to-
mography (4D-CT). FIG. 1 shows tumour tracking by
patient-specific DL in treatment workflow. The personal-
ized data generation and training process could be done
end-to-end automatically using treatment planning with
4D-CT data. Moreover, these processes could be done in
the treatment facility without taking patient data out of
the facility, avoiding privacy problems. The tracking is
performed during treatment, with the possibility of pre-
treatment rehearsal.
We validated the feasibility of our strategy by evaluati-
ing accuracy in both a digital phantom simulation study
and an epoxy phantom study.
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2FIG. 1. Procedure for markerless tumour tracking by
patient-specific DL in treatment workflow.
II. MATERIALS AND METHODS
A. Deep learning for markerless tracking
We designed a neural network model (FIG. 2) for 2-
class semantic segmentation based on a fully convolu-
tional neural network (FCN)[14]. Our model classifies
an input image to tumour area or background area pixel-
wise for markerless tumour tracking. We combined the
FCN with a pixel shuffle layer[15] instead of deconvolu-
tion layers for >15 fps (<66.7 ms/frame) real-time pro-
cessing. We used wider convolution sizes in our model
than typical FCN using deconvolution layers such as the
original FCN and U-net[16], because we needed not only
local textures but also non-local features such as tumour
contours to recognize the tumour. A pixel shuffle layer
is faster than deconvolution layers, making it suitable for
real-time processing.
FIG. 2. The neural network model based on FCN
combined with a pixel shuffle layer. F: Filter size. S:
Stride width. P: Padding size. The left-side image is an
input image and the right-side image is a labelled image
classified to tumour area (white) or background area
(black).
In the training process, we used DRRs generated from
each phantom’s 4D-CT as input images. Also, we used
labelled images classified to tumour area or background
area as teacher images. We explained the detail of train-
ing data set, namely, pairs of a training DRR and a la-
belled image, in the simulation study section and the
phantom study section (below). We trained models by
using softmax cross entropy as a loss function and using
Adam (adaptive moment estimation)[17] as an optimiza-
tion algorithm in 200 mini batches and 10 epochs. We
consider that Adam optimization is suitable for stable
and fast training for a variety of data sets without tun-
ing training parameters for each data set, because Adam
automatically updates a learning rate parameter in its
internal algorithm. Each projection view was trained in-
dependently by using each training data set.
B. The simulation study with a digital 4D-CT
phantom
1. Digital 4D-CT phantom
In the simulation study, a digital respiratory mo-
tion phantom including ribs and vertebrae in the form
of a 4D-CT (XCAT R©, Duke University, Durham NC,
USA)[18][19] was used. The XCAT consists of 512 ×
512× 400 voxels (1 mm3 voxel) and features 200 phases
between peak inhalation and peak exhalation.
We created a digital tumour motion phantom synchro-
nized with the XCAT respiratory motion with the same
spatial resolution. The digital tumour phantom motion
range was 40 mm in the superior-inferior (SI) direction,
the main component of respiratory motion. We created
3-cm spherical and 1.5×2.25×3-cm ovoid digital tumour
phantoms with CT values of 100 Hounsfield units (HU),
which are large enough to be overlapped by ribs.
2. Training data sets
We used only ten phases with the same phase interval
with the XCAT digital phantom, because 4D-CT gen-
erally consists of ten phases. DRRs were generated by
projecting each 4D-CT phase with the same projection
geometry as the two-view fluoroscopic tracking systems
in the epoxy phantom study. DRRs were 768×768 pixels
(388× 388 µm2 pixels), identical to the flat panel detec-
tor (FPD) in the epoxy phantom study (below). The
DRR generation algorithm was based on a ray tracing
algorithm[20] and was also used for patient positioning
with image registration[21][22].
We coupled an XCAT DRR and a tumour DRR using
4D-CT with the same projection geometry, allowing us
to acquire an XCAT DRR with a tumour as a training
DRR (FIG. 3).
We solved the problem of overlapping bone by using
large numbers of training DRRs generated with displac-
ing projection geometries to simulate a range of tumour
motion. These training DRRs used the digital tumour
phantom with overlapping bone. This solution also works
as data augmentation.
To generate the DRRs, we displaced projection geome-
try with 3-dimensional translation (x, y, z) and rotation
(ψ, ϕ, θ) of an X-ray tube/FPD, by −6 to +6 mm with
3-mm steps and −2◦ to +2◦ with 1◦ steps. We then ac-
quired 56 − 1 = 15, 624 DRRs per 4D-CT phase (FIG.
4). Finally, we acquired 156, 240 DRRs in ten 4D-CT
3FIG. 3. Generating XCAT digitally reconstructed
radiographs (DRRs) with a tumour as training DRRs
from XCAT and a digital motion tumour phantom on
4D-CT.
phases. Because we can interpolate and extrapolate tu-
mour motion in discrete 4D-CT phases, the geometric
displacements were calculated from the tumour phantom
motion range between 4D-CT phases.
We also generated large numbers of labelled images
corresponding to training DRRs. In a labelled image,
tumour area was calculated as the projection area of a
tumour in 4D-CT. The other area was labelled as back-
ground area. This allowed us to automatically generate
phantom-specific training data sets, namely pairs of a
training DRR and a labelled image.
3. Markerless tracking
DRRs for all 4D-CT phases with the same projection
geometry, without displacements, were used as tracking
images. These tracking images consisted of 200 frames
and were not included in the training data set.
A tumour coordinate was calculated from semantic
segmentation of a tracking image by using a phantom-
specific trained model for every frame. Trained models
output the ‘tumour score’ (0.0-1.0) pixel-wise. There-
fore, we were able to calculate a tumour coordinate as
the density centre weighted by pixel-wise tumour score
thresholding >0.5. Using the density centre potentially
allows acquisition of a tumour coordinate with sub-pixel
accuracy in a tracking image. Misdetections of a few
pixels had little effect on the density centre coordinate.
Therefore, we expected higher accuracy than that of ob-
ject detection methods outputting an object coordinate
directly, such as Faster R-CNN[23].
4. Tracking accuracy evaluation
The ground truth of a tumour coordinate is the den-
sity centre of a tumour DRR weighted by pixel values
with sub-pixel accuracy. We evaluated ‘tracking error’ as
the 2-dimensional distance between a tracking coordinate
and a ground truth coordinate in each view. We evalu-
ated not only absolute error on the isocentre in mm but
also relative error on FPD by pixel units, because track-
ing errors may be affected by pixel resolution. We defined
‘tracking accuracy’ as the ratio of frames satisfying <1
mm tracking error on the isocentre. Tracking accuracy
corresponds to gating accuracy in typical isotropic PTV-
to-CTV margins of 1 mm[24]. In case with no pixels
having a >0.5 tumour score, we considered that tumour
detection did not succeed in this frame.
C. The phantom study with an epoxy respiratory
motion phantom
1. Epoxy respiratory motion phantom
In the phantom study, we validated multi-modality
DL, which uses DRRs for training and X-ray images for
tracking, using an epoxy respiratory motion phantom.
A programmable respiratory motion phantom (Dynamic
Thorax Phantom MODEL 008A R©, Computerized Imag-
ing Reference Systems, Inc., Norfolk VA, USA) [25] was
used. This is an epoxy chest phantom with vertebrae
but no ribs. It allows the operator to change spherical
tumour size (1 cm, 2 cm and 3 cm diameter). The CT
values of the epoxy ‘tumours’ are approximately 30 HU.
A 4D-CT of the MODEL 008A phantom was acquired
(Aquilion ONE R©, Canon Medical Systems Corporation,
Otawara City, Japan) with different sized tumour phan-
toms. We marked phantom position with the CT scan-
ner’s laser markers to reposition the chest phantom for
tracking in fluoroscopy. We then guided a tumour phan-
tom on a rod in a sinusoidal motion (±20 mm ampli-
tude and 4 second cycle) in the SI direction. 4D-CT
phases were synchronized with tumour motion. This 4D-
CT consisted of 512× 512× 204 voxels (0.625× 0.625× 1
mm voxel) and ten phases for a full single respiratory cy-
cle (T00T90). Because 4D-CT was acquired in the same
manner as during treatment workflow, in discrete phases,
the 4D-CT imaging range of tumour motion was approx-
imately 38 mm, which was narrower than the actual tu-
mour motion range. Also, motion artefacts, which gave
the tumours a more strongly differentiated appearance
than most cases of inter- and intra-fractional changes,
were detected in some 4D-CT phases.
2. Training data sets
We generated large numbers of training DRRs with
displacing projection geometry from 4D-CT data of the
chest phantom to simulate a variety of tumour motion
patterns. We displaced the projection geometry by −6
to +6 mm with 3-mm steps and −2◦ to +2◦ with 1◦ steps,
respectively. We then acquired 56 = 15, 625 DRRs per
4D-CT phase (FIG. 5). Finally, we acquired 156, 250
DRRs in all ten 4D-CT phases. Because we can interpo-
late and extrapolate tumour motion in discrete 4D-CT
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FIG. 4. Examples of training digitally reconstructed radiographs (DRRs) of a spherical tumour phantom with
displaced projection geometry using digital phantoms. (x, y, z) and (ψ, ϕ, θ) are displacements from the original
projection geometry.
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FIG. 5. Examples of training digitally reconstructed radiographs (DRRs) of a 3-cm tumour phantom with
displaced projection geometry, random contrast transformation, and random noise. (x, y, z) and (ψ, ϕ, θ) are
displacements from the base projection geometry.
5phases, the geometry displacement range was decided by
the tumour motion range between 4D-CT phases.
In multi-modality DL using DRRs for training and X-
ray images for tracking, we faced the specific problem
of differences in image quality between DRRs and X-ray
images, caused mainly by beam hardening effect, scatter-
ing, sensitivity characteristics of FPDs, and shot noise.
Therefore, a DRR cannot be converted to an X-ray image
precisely, because pixel values of a DRR do not corre-
spond to pixel values of an X-ray image one-to-one. We
solved this problem by using large numbers of training
DRRs with random contrast transformation and random
noise addition.
The contrast variation range was decided by analysing
differences in contrast between DRRs and X-ray images.
We applied gamma transformation with random γ val-
ues (γ = 0.42.5) to each DRR as random contrast trans-
formation. We also added Gaussian noise (σ = 25) as
random noise such that the noise variation range was ±1
standard deviation of the X-ray image noise.
Just as in the simulation study, we also generated
large numbers of labelled images corresponding to train-
ing DRRs.
3. Markerless tracking
Two-view X-ray fluoroscopy images of the chest phan-
tom were simultaneously taken and marked with the laser
positioning system (SyncTraX FX4 R©, Shimadzu Corpo-
ration, Inc., Kyoto, Japan) [1] (FIG. 6). We manually
positioned the phantom as close as possible to its loca-
tion in the 4D-CT using the laser markers. Because we
had not yet constructed a synchronizing system between
X-ray fluoroscopy frame and measurement of tumour po-
sition, we acquired X-ray images at the 25 fixed tumour
positions on the same trajectory taken by the 4D-CT
with a tumour phantom inserted. The other structures
of the phantom except the ‘tumour’ were fixed at the
same position. The X-ray settings were 110 kV, 50 mA,
4 ms, the same as in our gold marker tracking. These
X-ray images consisted of 768 × 768 pixels (388 × 388
µm2 pixel). They were taken in slightly different posi-
tions than in the 4D-CT because of differences in phase
intervals.
We applied a Gaussian blur filter to each X-ray image
to simulate the same spatial resolution as training DRRs,
which was lower than that of X-ray images, because DRR
spatial resolution was limited by the CT spatial resolu-
tion (image quality of DRRs and X-ray images was close
to each other for multi-modality DL). These blurred X-
ray images were used as tracking images.
As in the simulation study, a tumour coordinate was
calculated from semantic segmentation of a tracking im-
age by using a phantom-specific trained model for every
frame. A tumour coordinate was calculated as the den-
sity centre of the tumour score with sub-pixel accuracy,
which was essentially unaffected by the Gaussian blur
FIG. 6. Geometry of the two-view X-ray fluoroscopy
imaging system SyncTraX FX4 R©with a radiotherapy
system. Two views cross at the isocentre without being
blocked by the gantry head. Source-object distance
(SOD) = 2353 mm. Source-image distance (SID) =
4172 mm.
filter.
4. Tracking accuracy evaluation
We measured displacement of a motion tumour rod
of MODEL 008A phantom as ground truth of the tu-
mour coordinate using a laser displacement meter (LK-
G155 R©, Keyence Inc., Osaka, Japan, <20 µm accuracy)
outside of the X-ray fields of view (FIG. 7). We had
previously calibrated between displacements of a tumour
phantom and tumour coordinates on X-ray images. We
then acquired tumour coordinates from displacements of
the tumour phantom at 25 different positions.
As in the simulation study, we evaluated not only ab-
solute error on the isocentre in mm but also relative error
on FPD by pixel units. Also, we evaluated ‘tracking ac-
curacy’.
D. Implementation
The personalized data generation process was pro-
grammed with C++ and CUDA R©(NVIDIA Corpora-
tion, Santa Clara CA, USA) running on the GPU.
The training process and the tracking process were pro-
grammed with Python with the open-source DL frame-
work Chainer (Preferred Networks, Inc., Tokyo, Japan),
running on the GPU.
All processes (i.e., personalized data generation, train-
ing, and tracking) were done with a single computer
(Windows R©7 64 bit, Intel Xeon CPU E5-2637 dual,
64GB RAM, Microsoft, Inc. Redmond WA, USA;
NVIDIA Quadro M6000 24GB GPU dual). Personal-
6FIG. 7. Tracking accuracy evaluation system using a
MODEL 008A phantom with a laser displacement
meter (a). We measured displacement of a motion
tumour rod of the MODEL 008A phantom outside both
X-ray fields of view.
ized data generation, training, and tracking were run as
two-view processes simultaneously by using dual GPUs.
III. RESULTS
A. Digital simulation study
FIG. 8 shows an example of a tracking image. There
were no false detections, extra-detections, outside the tu-
mour area, in spite of many similar rib structures in the
tracking image.
FIG. 9 shows the tracking error distribution for all
frames. The tracking error distribution was <1 mm on
the isocentre and almost <1 pixel on the FPD without
effects of pixel resolution in both views and with both
tumour shapes.
TABLE I shows a summary of tracking accuracy. We
achieved 100% tracking accuracy in both views and with
both tumour shapes in spite of overlying bone.
B. Epoxy phantom study
FIG. 10 shows an example of a tracking image. There
were no false detections in the search area using the 2-
and 3-cm tumours despite the tumour overlapping the
spine in view 2. However, there were false detections in
the search area in some frames using the 1-cm tumours.
FIG. 11 shows the tracking error distribution for all
frames. In the cases of the 2- and 3-cm tumours, the
tracking error distribution was almost <1 mm on the
isocentre and almost <5 pixels on the FPD without ef-
fects of pixel resolution in both views. However, with the
1-cm tumours, tracking error distribution was >1 mm,
and was worse than with the 2- and 3-cm tumours. A
common bias error for all tumour sizes by manual posi-
tioning of the phantom was not detected.
TABLE II shows a summary of tracking accuracy.
We achieved >94.7% tracking accuracy in 2- and 3-cm
tumours in spite of multi-modality DL using DRRs for
training and X-ray images for tracking. However, track-
ing accuracy with 1-cm tumours was only 40.3%.
C. Processing time
The personalized data generation processing took
about 9 hours to output 156, 250 DRRs into a hard
disk drive (HDD). This processing time is rate-limited by
HDD access. The training process took about 17 hours,
and is also rate-limited by HDD access. The tracking
process (except image reading) took 32.5± 4.7 ms/frame
(30.8 fps) for real-time processing.
IV. DISCUSSION
We proved the potential feasibility of a real-time mark-
erless tumour tracking framework for stereotactic lung
radiotherapy based on patient-specific DL with a person-
alized data generation strategy using a digital phantom
simulation study and an epoxy phantom study. The per-
sonalized data generation and training process could be
done end-to-end automatically between treatment plan-
ning and treatment, without manual procedures such
as template creation just before the treatment process
while a patient is positioned and fixed. Also, our frame-
work does not require cone beam CT (CBCT) data taken
while a patient is positioned. Therefore, our framework
has potential to improve treatment throughput and re-
duce patient burden, compared to some conventional
markerless tracking frameworks which require manual
procedures just before the treatment process or require
CBCT[8][9][10][11]. Also, our framework using DL with
a large personalized training data set has potential to im-
prove the robustness and accuracy of markerless track-
ing, compared to frameworks using conventional machine
learning with a small personalized training data set[12].
The digital simulation study had 100% tracking accu-
racy in spite of overlying bone. Also, as the tracking
errors were significantly smaller than the displacements
for training DRRs, they could be easily distinguished
from each other. These results indicate that our method
was able to learn tumour shape while ignoring overly-
ing bone by using training data sets with a variety of
overlying bone patterns. Also, we succeeded in tracking
both spherical and ovoid tumour phantoms. This result
indicates that our method has the potential to track all
varieties of tumour shape.
In the epoxy phantom study, we achieved >94.7%
tracking accuracy in 2- and 3-cm tumours in spite of
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FIG. 8. An example of a tracking image in the digital simulation study. A calculated tumour coordinate is the
centre of the green rectangle in the tracking image.
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FIG. 9. The 2-dimensional tracking error distribution on FPD for all frames in the digital simulation study. The
centre of a graph, the origin, means zero error. The scale units are one pixel on the FPD. The red circle means 1
mm error on the isocentre, the criteria for tracking accuracy.
TABLE I. Summary of tracking accuracy in the digital simulation study. Tracking error shows ‘mean error’ ±
‘standard deviation’ with (maximum error) for all frames.
View 1 View2
Tumour shape Spherical Ovoid Spherical Ovoid
Tracking accuracy 100% 100% 100% 100%
Isocentre 0.05 ± 0.02 0.05 ± 0.03 0.06 ± 0.03 0.07 ± 0.04
Tracking error [mm] (0.12) (0.13) (0.16) (0.25)
(Maximum error) FPD 0.22 ± 0.11 0.23 ± 0.13 0.27 ± 0.15 0.32 ± 0.20
[pixel] (0.56) (0.60) (0.72) (1.13)
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FIG. 10. An example of a tracking image in an epoxy phantom study. The calculated tumour coordinate is in the
centre of the green rectangle. The red rectangle is the search area for a tumour.
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FIG. 11. The 2-dimensional tracking error distribution on flat panel detectors (FPD) for all frames (except
>6-pixel errors) in the epoxy phantom study. The centre of a graph, the origin, means zero error. The scale units
are one pixel on FPD. The red circle means 1 mm error on the isocentre, the criteria of tracking accuracy.
TABLE II. Summary of tracking accuracy in the epoxy phantom study. Tracking error shows ‘mean error’ ±
‘standard deviation’ with (maximum error) for all frames.
View 1 View2
Tumour size 3 cm 2 cm 1 cm 3 cm 2 cm 1 cm
Tracking accuracy 100% 100% 73.1% 100% 94.7% 40.3%
Isocentre 0.3 ± 0.1 0.3 ± 0.1 0.6 ± 0.4 0.3 ± 0.2 0.5 ± 0.2 1.8 ± 4.7
Tracking error [mm] (0.5) (0.9) (1.8) (0.8) (1.3) (30.4)
(Maximum error) FPD 1.3 ± 0.4 1.5 ± 0.6 2.9 ± 1.9 1.5 ± 0.8 2.4 ± 1.1 8.4 ± 21
[pixel] (2.4) (4.0) (8.3) (3.6) (5.8) (139.8)
9multi-modality DL using DRRs for training and X-ray
images for tracking. This result indicates that we were
able to allow it to learn modality invariance characteris-
tics by using training data sets with a range of contrast
and noise. This was achieved despite discrete 4D-CT
phases and a narrower 4D-CT imaging range of tumour
motion. This result indicates its success at interpola-
tion and extrapolation of tumour motion. Also, this was
achieved without being affected by manual positioning
error despite the fixed bone structures. This result in-
dicates that our model did not learn only relative posi-
tional relationships between bone structures and a tu-
mour. However, we need additional evaluation of tu-
mour trajectories in all three dimensions, not only in
the SI direction, in order to validate its robustness for
irregular tumour motion compared with training data.
We achieved this accuracy despite motion artefact from
a tumour in 4D-CT. We consider that our method has
the potential to detect tumours regardless of motion in
4D-CT or inter- and intra-fractional changes in tumour
shape. However, we need additional evaluation with a
retrospective clinical study to validate its robustness. In
1-cm tumours, tracking was difficult because of the low
contrast of the X-ray images due to scattered radiation.
We required additional evaluation with 1-cm ‘tumours’ in
the digital simulation study, which ignores scattered radi-
ation. The tracking accuracy could be improved in these
small masses by improving the contrast variation algo-
rithm for training DRRs to simulate scattered radiation.
Currently, we have calculated a tumour coordinate using
only a present frame without temporal information such
as tumour coordinates in past frames. We may be able
to reduce tumour detection inaccuracies by using tempo-
ral information. In this case, we can evaluate tracking
accuracy by using irregular respiratory waveforms.
In the labelled image, tumour area was labelled as the
projection area of a tumour on the 4D-CT. But, in ac-
tual treatment workflow, tumour area can be labelled
as the planning target volume (PTV) or clinical target
volume (CTV) generated by treatment planning by pro-
jecting PTV or CTV to a training DRR. In this case, tu-
mour contours also can be acquired by positioning PTV
or CTV on the tumour centre coordinate during tracking.
We consider that patient-specific DL has the potential
to provide better accuracy for each patient than standard
DL using multiple-patient data sets. Patient-specific DL
can be considered overfitting for a specific patient. Gen-
erally speaking, standard DL provides good accuracy for
all patients. Conversely, overfitting provides better accu-
racy for a specific patient than standard DL.
The personalized data generation process and training
process took about 26 hours in total. These processes
have to be done between treatment planning and treat-
ment in the workflow. The training time of 26 hours
might not be problematic because, generally, treatment
commences about one week after treatment planning.
However, more than 24 hours may not be sufficient if our
method is applied for retraining or fine tuning during the
course of treatment, or for instance at an MRI linac. We
can substantially shorten these processing times by gen-
erating DRRs and training data sets in memory without
rate-limiting HDD accessibility.
The tracking process requires >15 fps (<66.7
ms/frame) real-time processing, so our tracking process
of 32.5 ms/frame (30.8 fps) is sufficient.
V. CONCLUSIONS
We proved the potential feasibility of a real-time mark-
erless tumour tracking framework for stereotactic lung
radiotherapy based on patient-specific DL with personal-
ized data generation by evaluating the tracking accuracy
in both digital phantom and epoxy phantom studies.
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